Acciones Lexagene Holdings Inc Toronto S.E.
Acciones
WEY
CA52886L1031
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Jeffrey Mitchell
DFI | Director of Finance/CFO | - | 01/03/18 |
Steven Armstrong
COO | Chief Operating Officer | - | 24/03/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Joseph P. Caruso
BRD | Director/Board Member | 65 | 18/06/18 |
Jack Regan
CEO | Chief Executive Officer | - | 26/04/07 |
Tom Slezak
BRD | Director/Board Member | - | 12/10/16 |
Varia. 1 de ene. | Capi. | |
---|---|---|
-39,38 % | 8276,16 M | |
+9,28 % | 3617,23 M | |
-1,48 % | 2241,46 M | |
-22,85 % | 1944,86 M | |
-18,07 % | 1723,14 M | |
+10,53 % | 962 M | |
+17,17 % | 734 M | |
-9,17 % | 690 M | |
-33,88 % | 477 M |